Morgan Stanley Regenxbio Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Regenxbio Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,339,838 shares of RGNX stock, worth $14.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,339,838

Previous 1,820,382 26.4%

Holding current value

$14.4 Million

Previous $32.7 Million 13.6%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $5.85 Million - $11.8 Million	-480,544 Reduced 26.4%	1,339,838 $28.2 Million
Q4 2023 Feb 13, 2024	BUY	$12.89 - $20.82 $18.5 Million - $29.9 Million	1,438,467 Added 376.65%	1,820,382 $32.7 Million
Q3 2023 Nov 15, 2023	BUY	$16.46 - $19.99 $59,074 - $71,744	3,589 Added 0.95%	381,915 $6.29 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $857,382 - $1.08 Million	49,761 Added 15.14%	378,326 $7.56 Million
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $336,215 - $456,531	18,596 Added 6.0%	328,565 $6.21 Million

Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $777,321 - $942,311	-38,104 Reduced 10.95%	309,969 $7.03 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $3.54 Million - $5.56 Million	-158,675 Reduced 31.31%	348,073 $9.2 Million
Q2 2022 Oct 27, 2022	BUY	$19.35 - $35.04 $1.99 Million - $3.61 Million	102,901 Added 25.48%	506,748 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $1.99 Million - $3.61 Million	102,901 Added 25.48%	506,748 $12.5 Million
Q1 2022 Oct 27, 2022	SELL	$24.62 - $34.31 $2.53 Million - $3.53 Million	-102,901 Reduced 20.31%	403,847 $13.4 Million
Q1 2022 May 13, 2022	SELL	$24.62 - $34.31 $748,940 - $1.04 Million	-30,420 Reduced 7.0%	403,847 $13.4 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $2.81 Million - $3.75 Million	93,111 Added 27.29%	434,267 $14.2 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $9.92 Million - $15.6 Million	341,156 New	341,156 $14.3 Million

Others Institutions Holding RGNX

# of Institutions

192

Shares Held

42.1M

Call Options Held

80.6K

Put Options Held

55.2K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $465M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account